Objective parameters to define chemotherapy-induced ovarian failure [14] are follicle-stimulating hormone (FSH) and serum estradiol serum; while anti-Mullerian hormone (AMH) and antral follicle count (AFC) at ultrasound imaging are used to define the ovarian reserve [15]. This evidence concerns the gene BRD2 and ovarian dysfunction.